• The relationship between semaphorin 3C and microvessel density in the progression of breast and oral neoplasia
  Catalog No.:BS3705        Pubmed No.:25910410        PMCID:
  Details:
  Journal name:
• Anti-angiogenic activities of CRBGP from buccal glands of lampreys (Lampetra japonica)
  Catalog No.:BS13278        Pubmed No.:26616010        PMCID:
  Details:
  Journal name:
• Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways
  Catalog No.:BS13278        Pubmed No.:29268190        PMCID:
  Details:
  Journal name:
• Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways
  Catalog No.:BS12478        Pubmed No.:29268190        PMCID:
  Details:
  Journal name:
• Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways
  Catalog No.:AP0060        Pubmed No.:29268190        PMCID:
  Details:
  Journal name:
• Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways
  Catalog No.:BS70000        Pubmed No.:29268190        PMCID:
  Details:
  Journal name:
• Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways
  Catalog No.:BS90866        Pubmed No.:29268190        PMCID:
  Details:
  Journal name:
• Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways
  Catalog No.:BS1697        Pubmed No.:29268190        PMCID:
  Details:
  Journal name:
• Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways
  Catalog No.:BS90633        Pubmed No.:29268190        PMCID:
  Details:
  Journal name:
• Treatment with NAD+ inhibited experimental autoimmune encephalomyelitis by activating AMPK/SIRT1 signaling pathway and modulating Th1/Th17 immune responses in mice
  Catalog No.:AP0063        Pubmed No.:27500459        PMCID:
  Details:
  Journal name:
• Ampelopsin attenuates lipopolysaccharide-induced inflammatory response through the inhibition of the NF-κB and JAK2/STAT3 signaling pathways in microglia
  Catalog No.:AP0063        Pubmed No.:27998743        PMCID:
  Details:
  Journal name:
• Ampelopsin attenuates lipopolysaccharide-induced inflammatory response through the inhibition of the NF-κB and JAK2/STAT3 signaling pathways in microglia
  Catalog No.:BLH01S100CN        Pubmed No.:27998743        PMCID:
  Details:
  Journal name:
• The correlation between inflammatory injury induced by LPS and RAS in EpH4-Ev cells
  Catalog No.:AP0063        Pubmed No.:28249221        PMCID:
  Details:
  Journal name:
• Bergapten prevents lipopolysaccharide-induced inflammation in RAW264.7 cells through suppressing JAK/STAT activation and ROS production and increases the survival rate of mice after LPS challenge
  Catalog No.:AP0060        Pubmed No.:28511114        PMCID:
  Details:
  Journal name:
• Resokaempferol-mediated anti-inflammatory effects on activated macrophages via the inhibition of JAK2/STAT3, NF-κB and JNK/p38 MAPK signaling pathways
  Catalog No.:BS65564        Pubmed No.:27261558        PMCID:
  Details:
  Journal name: